Home › Companies › Health Catalyst, Inc. › 2025-2026

Health Catalyst, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Health Catalyst, Inc.’s Form 8-K, filed 2025-07-10 (Item 5.07 on EDGAR). Page generated 04 October 2026.

6Reported items
165Asset managers
952Fund votes
2025-07-09Meeting date

Proxy season: 2023-2024 2025-2026

Explore Health Catalyst, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Health Catalyst, Inc.

These tallies are Health Catalyst, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-07-10 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Health Catalyst, Inc. — official shareholder meeting results, meeting held 2025-07-09
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Duncan Gallagher	37,136,561	--	--	9,402,545	6,586,735	Majority: yes
Elect Director: Dr. Jill Hoggard Green	45,320,332	--	--	1,218,774	6,586,735	Majority: yes
Proposal 2: Ratification of the Appointment of the Company's Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of Ernst & Young LLP to perform the audit of the Company's consolidated financial statements for the	53,070,196	26,656	28,989	--	--	Majority: yes
Proposal 3: Advisory, Non-Binding Vote to Approve the Compensation of the Company's Named Executive Officers The stockholders approved the advisory, non-binding proposal to approve the compensation of the Company's named executive officers	45,000,705	768,325	770,076	--	6,586,735	Majority: yes
Proposal 4: Advisory, Non-Binding Vote to Approve the Board of Directors Initiating Action to Declassify our Board of Directors of the Company The stockholders approved the advisory, non-binding proposal to approve the board of directors of the Company (the "B	46,174,256	345,811	19,039	--	6,586,735	Majority: yes

Source: Health Catalyst, Inc., Form 8-K, filed with the SEC on 2025-07-10 — read the filing on EDGAR.

How asset managers voted at the Health Catalyst, Inc. 2025-2026 meeting

Each item below shows how the 165 asset managers that disclosed a Health Catalyst, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Health Catalyst, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on an advisory, non-binding basis, the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 45,000,705AGAINST: 768,325

Health Catalyst, Inc.’s own tally for this item (“Proposal 3: Advisory, Non-Binding Vote to Approve the Compensation of the Company's Named Executive Officers The stockholders approved the advisory, non-binding proposal to approve the compensation of the Company's named”): 45,000,705 for, 768,325 against, per its Form 8-K filed 2025-07-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 69,601,233 outstanding shares: 65% for, 1% against (66% of the company cast a for/against vote).

The 163 asset managers below cast 99.4% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 99.3%

FOR: 99.4%AGAINST: 0.5%ABSTAIN: 0.1%

Largest asset managers voting on “To approve, on an advisory, non-binding basis, the compensation of our named executive officers.” at Health Catalyst, Inc., 2025-2026
Asset manager	For	Against	Vote
First Light Asset Management, LLC	11,523,422	0	For
BlackRock	4,637,654	0	For
Vanguard	4,104,676	0	For
IMPAX ASSET MANAGEMENT LLC	2,750,000	0	For
IMPAX FUNDS SERIES TRUST I	2,750,000	0	For
Fidelity	2,643,312	0	For
PRIMECAP MANAGEMENT CO/CA/	1,986,687	0	For
PRIMECAP Odyssey Funds	1,686,170	0	For
Portolan Capital Management, LLC	1,602,908	0	For
Whetstone Capital Advisors, LLC	1,557,169	0	For
GEODE CAPITAL MANAGEMENT, LLC	1,509,827	0	For
Wellington	1,259,468	0	For
KENNEDY CAPITAL MANAGEMENT LLC	1,144,626	0	For
State Street	1,062,389	899	For
Charles Schwab	988,809	0	For
Dimensional	987,609	0	For
ACADIAN ASSET MANAGEMENT LLC	733,292	0	For
Nuveen	555,646	0	For
TIAA	547,943	0	For
Northern Trust	495,062	0	For
MARTIN & CO INC /TN/	426,308	0	For
JPMorgan	415,487	0	For
Goldman Sachs	318,640	0	For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	316,029	0	For
MFS	316,029	0	For

Showing the 25 largest of 163 asset managers. See all 163 in the interactive database.

2. TO APPROVE, ON AN ADVISORY, NON-BINDING BASIS, THE BOARD INITIATING ACTION TO DECLASSIFY THE BOARD.

CORPORATE GOVERNANCEMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%

FOR: 46,174,256AGAINST: 345,811

Health Catalyst, Inc.’s own tally for this item (“Proposal 4: Advisory, Non-Binding Vote to Approve the Board of Directors Initiating Action to Declassify our Board of Directors of the Company The stockholders approved the advisory, non-binding proposal to approve the b”): 46,174,256 for, 345,811 against, per its Form 8-K filed 2025-07-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 69,601,233 outstanding shares: 66% for, 0.5% against (67% of the company cast a for/against vote).

The 53 asset managers below cast 100% of the shares they voted on this item FOR (18,058,077 for, 0 against).

FOR 100%

FOR: 18,058,077 (100.0%)

Largest asset managers voting on “TO APPROVE, ON AN ADVISORY, NON-BINDING BASIS, THE BOARD INITIATING ACTION TO DECLASSIFY THE BOARD.” at Health Catalyst, Inc., 2025-2026
Asset manager	For	Vote
Vanguard	3,963,742	For
IMPAX FUNDS SERIES TRUST I	2,750,000	For
BlackRock	2,676,146	For
Fidelity	2,463,945	For
PRIMECAP Odyssey Funds	1,686,170	For
Dimensional	827,671	For
TIAA	547,943	For
Charles Schwab	494,273	For
JPMorgan	415,487	For
MFS	316,029	For
Goldman Sachs	238,079	For
ALGER FUNDS	164,541	For
Equitable	147,623	For
Lincoln Financial	133,407	For
American Century	110,776	For
QUANTITATIVE MASTER SERIES LLC	100,811	For
ALGER PORTFOLIOS	88,344	For
Brighthouse	81,596	For
Northern Lights Fund Trust IV	79,682	For
AIG/SunAmerica	76,693	For
Principal Exchange-Traded Funds	64,475	For
Zacks Trust	62,665	For
Voya	61,849	For
ALGER INSTITUTIONAL FUNDS	54,201	For
Putnam	41,051	For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

3. RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF HEALTH CATALYST, INC. FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 53,070,196AGAINST: 26,656

Health Catalyst, Inc.’s own tally for this item (“Proposal 2: Ratification of the Appointment of the Company's Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of Ernst & Young LLP to perform the audit of the Company's co”): 53,070,196 for, 26,656 against, per its Form 8-K filed 2025-07-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 69,601,233 outstanding shares: 76% for, 0.1% against (76% of the company cast a for/against vote).

The 53 asset managers below cast 100% of the shares they voted on this item FOR (18,046,052 for, 0 against).

FOR 99.9%

FOR: 18,046,052 (99.9%)ABSTAIN: 12,025 (0.1%)

Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF H” at Health Catalyst, Inc., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	3,963,742	0	For
IMPAX FUNDS SERIES TRUST I	2,750,000	0	For
BlackRock	2,676,146	0	For
Fidelity	2,463,945	0	For
PRIMECAP Odyssey Funds	1,686,170	0	For
Dimensional	827,671	0	For
TIAA	547,943	0	For
Charles Schwab	494,273	0	For
JPMorgan	415,487	0	For
MFS	316,029	0	For
Goldman Sachs	238,079	0	For
ALGER FUNDS	164,541	0	For
Equitable	147,623	0	For
Lincoln Financial	133,407	0	For
American Century	110,776	0	For
QUANTITATIVE MASTER SERIES LLC	100,811	0	For
ALGER PORTFOLIOS	88,344	0	For
Brighthouse	69,571	12,025	For
Northern Lights Fund Trust IV	79,682	0	For
AIG/SunAmerica	76,693	0	For
Principal Exchange-Traded Funds	64,475	0	For
Zacks Trust	62,665	0	For
Voya	61,849	0	For
ALGER INSTITUTIONAL FUNDS	54,201	0	For
Putnam	41,051	0	For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

4. Election of two Class III Directors for a term of three years until the 2028 annual meeting of the stockholders or until their successors are duly elected and qualified, subject to their earlier removal or resignation: Dr. Jill Hoggard Green

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 45,320,332WITHHELD: 1,218,774

Health Catalyst, Inc.’s own tally for this item (“Elect Director: Dr. Jill Hoggard Green”): 45,320,332 for, 1,218,774 withheld, per its Form 8-K filed 2025-07-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 69,601,233 outstanding shares: 65% for, 2% withheld (67% of the company cast a for/withheld vote).

The 51 asset managers below cast 100% of the shares they voted on this item FOR (17,975,336 for, 0 against).

FOR 99.9%

FOR: 17,975,336 (99.9%)ABSTAIN: 12,266 (0.1%)

Largest asset managers voting on “Election of two Class III Directors for a term of three years until the 2028 annual meeting of the stockholder” at Health Catalyst, Inc., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	3,963,742	0	For
IMPAX FUNDS SERIES TRUST I	2,750,000	0	For
BlackRock	2,676,146	0	For
Fidelity	2,463,945	0	For
PRIMECAP Odyssey Funds	1,686,170	0	For
Dimensional	827,671	0	For
TIAA	547,943	0	For
Charles Schwab	494,273	0	For
JPMorgan	415,487	0	For
MFS	316,029	0	For
Goldman Sachs	238,079	0	For
ALGER FUNDS	164,541	0	For
Equitable	147,623	0	For
Lincoln Financial	133,407	0	For
American Century	110,776	0	For
QUANTITATIVE MASTER SERIES LLC	100,811	0	For
ALGER PORTFOLIOS	88,344	0	For
Brighthouse	69,571	12,025	For
Northern Lights Fund Trust IV	79,682	0	For
AIG/SunAmerica	76,693	0	For
Principal Exchange-Traded Funds	64,475	0	For
Voya	61,849	0	For
ALGER INSTITUTIONAL FUNDS	54,201	0	For
Putnam	41,051	0	For
MASTER INVESTMENT PORTFOLIO	37,093	0	For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

5. Election of two Class III Directors for a term of three years until the 2028 annual meeting of the stockholders or until their successors are duly elected and qualified, subject to their earlier removal or resignation: Duncan Gallagher

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

80% Majority: yes · of votes cast

FOR 80%WITHHELD 20%

FOR: 37,136,561WITHHELD: 9,402,545

Health Catalyst, Inc.’s own tally for this item (“Elect Director: Duncan Gallagher”): 37,136,561 for, 9,402,545 withheld, per its Form 8-K filed 2025-07-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 69,601,233 outstanding shares: 53.4% for, 14% withheld (67% of the company cast a for/withheld vote).

The 51 asset managers below cast 100% of the shares they voted on this item FOR (14,763,775 for, 0 against).

FOR 82%ABSTAIN 18%

FOR: 14,763,775 (82.1%)ABSTAIN: 3,223,827 (17.9%)

Largest asset managers voting on “Election of two Class III Directors for a term of three years until the 2028 annual meeting of the stockholder” at Health Catalyst, Inc., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	3,963,742	0	For
IMPAX FUNDS SERIES TRUST I	2,750,000	0	For
BlackRock	2,676,146	0	For
Fidelity	1,496,430	967,515	For
PRIMECAP Odyssey Funds	1,686,170	0	For
Dimensional	0	827,671	Abstain
TIAA	547,943	0	For
Charles Schwab	494,273	0	For
JPMorgan	415,487	0	For
MFS	0	316,029	Abstain
Goldman Sachs	0	238,079	Abstain
ALGER FUNDS	0	164,541	Abstain
Equitable	147,623	0	For
Lincoln Financial	93,755	39,652	For
American Century	0	110,776	Abstain
QUANTITATIVE MASTER SERIES LLC	100,811	0	For
ALGER PORTFOLIOS	0	88,344	Abstain
Brighthouse	44,100	37,496	For
Northern Lights Fund Trust IV	79,682	0	For
AIG/SunAmerica	0	76,693	Abstain
Principal Exchange-Traded Funds	0	64,475	Abstain
Voya	0	61,849	Abstain
ALGER INSTITUTIONAL FUNDS	0	54,201	Abstain
Putnam	41,051	0	For
MASTER INVESTMENT PORTFOLIO	37,093	0	For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

6. DIRECTOR

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (70,475 for, 0 against).

FOR: 70,475 (100.0%)

Largest asset managers voting on “DIRECTOR” at Health Catalyst, Inc., 2025-2026
Asset manager	For	Against	Abstain	Withheld	Vote
Zacks Trust	62,665	0	0	0	For
SARATOGA ADVANTAGE TRUST	7,810	0	0	0	For

Largest Health Catalyst, Inc. shareholders voting in 2025-2026

Ranked by the number of Health Catalyst, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 69,601,233 shares outstanding at the time of that meeting.

Top Health Catalyst, Inc. shareholders by shares voted, 2025-2026
#	Asset manager	% of shares outstanding
1	First Light Asset Management, LLC	16.56%
2	BlackRock	6.66%
3	Vanguard	5.90%
4	IMPAX ASSET MANAGEMENT LLC	3.95%
5	IMPAX FUNDS SERIES TRUST I	3.95%
6	Fidelity	3.80%
7	PRIMECAP MANAGEMENT CO/CA/	2.85%
8	PRIMECAP Odyssey Funds	2.42%
9	Portolan Capital Management, LLC	2.30%
10	Whetstone Capital Advisors, LLC	2.24%

Reported Health Catalyst, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Health Catalyst, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
First Light Asset Management, LLC	18.51%	13D
Stoney Lonesome HF LP	9.73%	13G
Palogic Value Management, LP	7.72%	13D
BlackRock	7.38%	13F
Vanguard Group	6.37%	13F
Impax Asset Management Group plc	5.75%	13G
Geode Capital	2.16%	13F
State Street	1.90%	13F
JPMorgan Chase	0.97%	13F
Charles Schwab	0.87%	13F

Percentages above are of 69,601,233 shares outstanding, as reported by Health Catalyst, Inc. on its Form 10-Q dated 2025-05-05 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Health Catalyst, Inc.’s 10-Q dated 2025-05-05. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At Health Catalyst, Inc.'s shareholder meeting held 2025-07-09, in the 2025-2026 proxy season, 165 asset managers reported how they voted in their SEC Form N-PX filings, covering 952 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory, non-binding basis, the compensation of our named executive officers. — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Health Catalyst, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-07-10.

Health Catalyst, Inc. proxy season coverage: 2023-2024 · 2025-2026 (this page).